cardiologists news from FierceHealthcare
News
DoJ joins whistle-blower suit against OH MDs, hospital
HHS Ok's hospital/physician gainsharing
Study: Nurse-driven heart failure support boosts compliance
Study: Drug coated stents may be safe
Cardiologist investigated for allegedly striking patient
SPOTLIGHT: Stent problems change cardiology tactics
Study: Too few patients get clot-busting drugs
Pediatric stent-maker faces FDA investigation
A company that makes coronary stents and catheters for pediatric use is facing an investigation by the FDA and federal prosecutors, who contend that it promoted non-approved stents for use in children. They say device maker NuMed sold more than 30 stents to the DuPont Hospital for Children in Wilmington, Del., but didn't file for FDA approval prior to selling the stents as agency regs require. If the FDA investigation moves forward, NuMed ultimately could be banned from selling the …
Read more...Study:Primary care costs, reimbursement low
Primary care costs much less than specialty care, but insurers aren't necessarily taking that into account, according to a new study. The study, by HHS's Agency for Healthcare Research and Quality, noted that while orthopedist fees averaged $210 per visit, and cardiologists $232 per visit, primary care physicians typically charge $100 per visit. But insurers still penalize primary care, requiring patients to pay an average of 20 percent of PCP costs out-of-pocket. Despite higher costs, …
Read more...ALSO NOTED: Revolution Health launches; TX leads in uninsured rolls; and much more...
> Closely-watched consumer health site RevolutionHealth.com should launch this week. The project is funded by AOL founder Steve Case. Article
> Texas has the nation's highest rate of uninsured citizens, researchers say. Article
> Experts are arguing that The Global Fund should pay for health worker salaries, not …
Read more...Get more cardiologists coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




